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Abstract
Background: Survival and linear-quadratic model fitting parameters implemented in
treatment planning for targeted radionuclide therapy depend on accurate cellular
dosimetry. Therefore, we have built a refined cellular dosimetry model for [177Lu]Lu-
DOTA-[Tyr3]octreotate (177Lu-DOTATATE) in vitro experiments, accounting for specific
cell morphologies and sub-cellular radioactivity distributions.
Methods: Time activity curves were measured and modeled for medium,
membrane-bound, and internalized activity fractions over 6 days. Clonogenic survival
assays were performed at various added activities (0.1–2.5 MBq/ml). 3D microscopy
images (stained for cytoplasm, nucleus, and Golgi) were used as reference for
developing polygonal meshes (PM) in 3DsMax to accurately render the cellular and
organelle geometry. Absorbed doses to the nucleus per decay (S values) were
calculated for 3 cellular morphologies: spheres (MIRDcell), truncated cone-shaped
constructive solid geometry (CSG within MCNP6.1), and realistic PM models, using
Geant4-10.03. The geometrical set-up of the clonogenic survival assays was modeled,
including dynamic changes in proliferation, proximity variations, and cell death. The
absorbed dose to the nucleus by the radioactive source cell (self-dose) and
surrounding source cells (cross-dose) was calculated applying the MIRD formalism.
Finally, the correlation between absorbed dose and survival fraction was fitted using
a linear dose-response curve (high α/β or fast sub-lethal damage repair half-life) for
different assumptions, related to cellular shape and localization of the internalized
fraction of activity.
Results: The cross-dose, depending on cell proximity and colony formation, is a
minor (15%) contributor to the total absorbed dose. Cellular volume (inverse
exponential trend), shape modeling (up to 65%), and internalized source localization
(up to + 149% comparing cytoplasm to Golgi) significantly influence the self-dose to
nucleus. The absorbed dose delivered to the nucleus during a clonogenic survival assay
is 3-fold higher with MIRDcell compared to the polygonal mesh structures. Our cellular
dosimetry model indicates that 177Lu-DOTATATE treatment might be more effective
than suggested by average spherical cell dosimetry, predicting a lower absorbed dose
for the same cellular survival. Dose-rate effects and heterogeneous dose delivery might
account for differences in dose-response compared to x-ray irradiation.
(Continued on next page)
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Conclusion: Our results demonstrate that modeling of cellular and organelle geometry
is crucial to perform accurate in vitro dosimetry.
Keywords: Cellular dosimetry, [177Lu]Lu-DOTA-[Tyr3]octreotate, Polygonal mesh, S
values, in vitro cytotoxicity correlation
Background
Targeted radionuclide therapy (TRT) is a promising treatment for solid tumors and mi-
cro metastases [1]. Patients with metastasized neuroendocrine tumors (NETs) overex-
pressing the somatostatin receptor type 2 (SST2) can be treated with peptide receptor
radionuclide therapy (PRRT). PRRT with the radiolabeled somatostatin receptor agonist
DOTA-[Tyr3]octreotate ([177Lu]Lu-DOTA-[Tyr3]octreotate or 177Lu-DOTATATE) has
successfully been employed in the past years [2].
Clinical optimization of TRT most often relies on the evaluation of the absorbed
dose-effect relationship in pre-clinical settings aiming to assess efficacy and toxicity of
the treatment. The fundamental knowledge derived from a better understanding of the
action of ionizing radiation on biological matter through the development of cellular
dosimetry may provide novel and more effective strategies for TRT treatment delivery.
However, biological effects from in vitro experiments are mainly reported in direct cor-
relation with the added activities (in MBq/ml), hindering the prediction and compari-
son of therapeutic efficacy of different radiopharmaceuticals.
For this purpose, the Medical Internal Radiation Dose (MIRD) committee has devel-
oped a general formalism to convert administered activities into absorbed doses based
on the S value [3], i.e., the absorbed dose-rate to a target region per unit activity from a
source region. This concept, initially adopted at organ level, has been extended to the
cellular level leading to the creation of a database of cellular S values for several cell/
nucleus radii and radionuclides incorporated into different compartments [4] included
in MIRDcell [5], an applet software application.
This tool, however, has several limitations related mainly to simplified biological as-
sumptions (e.g., spherical cell geometry lacking a physical membrane, unit density, and
uniform activity distributions) and a semi-analytical radiation transport model adopting
the continuous-slowing-down approximation (CSDA), thus neglecting electron strag-
gling and secondary electrons. Indeed, other authors made use of pre-calculated Dose
Point Kernels [6, 7] or direct Monte Carlo radiation transport [8–10], pointing out the
discrepancy with MIRDcell, specifically for the low energy range of electrons [11].
Moreover, it was demonstrated that asymmetries in the geometry [12, 13], as well as
non-concentric cell and nucleus morphology [14] significantly impact the absorbed
dose to the nucleus. Hence, a realistic geometrical representation of the cell, including
organelles that can play a key role in the re-localization of the radiopharmaceutical
product, such as the Golgi apparatus, is indispensable to perform proper cellular dos-
imetry. The Golgi apparatus is an intracellular membrane system located near the cell
nucleus and responsible for processing of proteins. After receptor agonist stimulation,
the SST2 will be internalized into the cell and is either directly recycled to the plasma
membrane or is relocated to the trans-Golgi network [15]. It remains yet to be deter-
mined whether the receptor agonist remains bound to the receptor during the
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relocation or if it is released; however, the impact of the radiopharmaceutical
localization in the Golgi, besides cytoplasm and membrane, has never been assessed.
Further development is needed in cellular dosimetry to investigate reliable dose-effect
relationships for cell survival. These models can then be integrated into treatment plan-
ning systems for TRT. Conversely, in external beam radiotherapy (EBRT) the well-
established linear-quadratic (LQ) model [16] is used to describe the response to radi-
ation; however, it remains yet to be determined if the LQ-model would be able to de-
scribe the variable low-dose rate and heterogeneous dose delivery characterizing PRRT.
Hence, the present work aims to build a more refined dosimetry model, based on the
MIRD formalism, for in vitro cell experiments with 177Lu-DOTATATE and correlate
the cellular absorbed doses to cell survival in order to compare it to x-ray exposure and
LQ-model prediction.
Methods
Cell lines and treatment
Experiments were performed with human osteosarcoma cells (U2OS) stably expressing
somatostatin receptor type 2 (U2OS+SST2) and maintained as previously described
[17]. For uptake and survival experiments, cells were treated with different activity
quantities of 177Lu-DOTATATE (IDB Holland). Molar activity was 53 MBq/nmol,
radiometal incorporation > 95% and radiochemical purity > 90%.
Immunofluorescent staining and imaging
Cells were grown on quartz coverslips (Xantec bioanalytics GmbH, Düsseldorf, Germany)
in 6-well plates until ~ 25% confluency and fixed with 2% paraformaldehyde (Sigma Al-
drich) for 15min at room temperature (RT), permeabilized for 20min at RT in PBS con-
taining 0.1% Triton X-100 (Sigma Aldrich), and incubated in blocking buffer (PBS, 0.1%
Triton X-100, 2% bovine serum albumin (Sigma Aldrich)) for 30min at RT. Next, cells were
incubated for 90min at RT with the primary antibody, rabbit anti-Giantin (PRB-114C Bio-
Legend, San Diego, CA, USA, 1/1000) diluted in blocking buffer. Following incubation, cells
were washed with PBS 0.1% Triton X-100 and incubated with 100nM SiR-actin (SC001
Spirochrome) and the secondary antibody (goat anti-rabbit Alexa Fluor 488 1/1000) in
blocking buffer for 90min at RT. Cells were washed with PBS and incubated with 1 μg/ml
propidium iodide (Sigma Aldrich) and 10 μg/ml RNase in PBS for 30 min at RT. Cells were
washed with PBS and mounted in 87% glycerol pH8.6 (Sigma Aldrich). Z-stack imaging was
performed using a 4Pi confocal microscope (Leica, Mannheim, Germany) and images were
analyzed using the ImageJ software [18].
Uptake assay
U2OS+SST2 cells were seeded in 12-well plates and the next day cells were incubated
with 0.5, 1, and 2.5 MBq/ml of 177Lu-DOTATATE in 1 mL medium for 15 min up to
4 h at 37 °C, 5% CO2. Subsequently, cells were washed with PBS. For short-term mea-
surements, samples were collected every 15 min. The membrane-bound fraction was
collected by incubating cells for 10 min in 1 mL 50mM glycine (Sigma Aldrich) and
100 mM NaCl (Sigma Aldrich), pH 2.8. The internalized fraction was collected by lysing
the cells 1 mL 0.1M NaOH (Sigma Aldrich). For day 1–6 measurements, a new
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medium was added to the cells and they were incubated at 37 °C, 5% CO2. For every
time point, medium, membrane-bound, and internalized fractions were collected. This
data was combined with the uptake data (2.5 MBq/ml) from the previous study [17].
Gamma counter measurements were corrected for decay and the uncertainty on esti-
mated activity fractions in the different cell compartments was calculated as one stand-
ard deviation of 2 independent experiments, each performed in triplicate. Fractions of
added activity were also determined for activities of 0.1 and 0.25MBq/ml by 3D inverse
distance weighting extrapolation using Python [19]. Furthermore, total cell number per
well was measured using a CASY cell counter (OMNI Life Science).
Clonogenic survival assay
Cells were incubated with 0.1-2.5 MBq/ml of 177Lu-DOTATATE for 4 h and clonogenic
potential was measured at 8 days after treatment as previously described [17]. New data
was combined with survival data from the previous study by Nonnekens et al. [17] to
investigate the reproducibility of these experiments.
In order to compare these results to external irradiation, cells were seeded in a 6-well
plate and 6 h later irradiated with 86 keV x-ray (0.5–4 Gy). Clonogenic potential was
measured at 8 days after treatment.
Monte Carlo simulations: cellular shape assumptions and software choice
Three geometrical modeling assumptions were used to render the cellular shape, as ob-
tained through 4Pi confocal microscopy imaging: MIRDcell (spheres), truncated cone-
shaped constructive solid geometry (CSG) and realistic cell representations, based on
(1) voxels (2.77 μm× 2.77 μm× 1.3 μm) and (2) polygonal mesh structures (PM) (2D in-
terconnected surfaces) (Fig. 1). The CSG-based shape was constructed as reported in
Table 1 and will be referred to as truncated cone geometry.
In order to calculate the S values for the truncated cone and voxelized geom-
etries, the F6 tally (i.e., calculation of the absorbed dose in kerma approximation)
was used within the Monte Carlo N-Particle 6.1 code [20]. The minimum voxel-
size was limited by internal source sampling. The electron cut-off energy was
lowered to 100 eV and 20 eV to extend the electron transport to microscopic
scales [21].
Currently, MCNP 6.1 does not allow to import PMs, therefore Geant4 10.3 [22]
was used instead. 3Ds Max [23] was used to model the specific morphology of
cytoplasm, nucleus and Golgi of 9 4Pi confocal microscopy 3D images (Fig. 2),
Fig. 1 Cellular shape modeling assumptions: a Truncated cone, b Voxelized geometry, c Polygonal
mesh structure
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while the shell operator was employed to add the cell surface. Each cellular struc-
ture was saved with the highest numerical precision available (12 decimals) and
converted into GDML format with FASTRAD [24]. “Penelope” low energy physics
model [25] was adopted in Geant4 to track particles down to an energy of 250
eV (cut-off range of 10 nm) while the default production threshold of secondary
electrons was lowered to 1 nm and the step size was limited to 1 μm when
needed.
The chemical composition of the cell nucleus was taken to be that of normal
cells [26], while cytoplasm and Golgi were considered as water (ρ = 1 g/cm3) and
cell membrane as lipid (ρ = 0.92 g/cm3). The β-spectrum of lutetium-177 was sam-
pled according to RADAR decay data (starting at 3.8 keV) since only electrons
above 6 keV are expected to travel at least a distance of 1 μm (average Golgi-
nucleus path) [11]. Auger- and internal conversion electron data were taken from
ICRP107 [27]. The radionuclide was considered to be uniformly distributed in cell
growth medium (M), cell membrane, cytoplasm or Golgi. The number of particles
run per simulation ensured a relative error below 1%. A computational cluster pro-
viding 648 CPU cores (MCNP6.1) and a relatively high-end hardware (Intel Xeon
W-2133 CPU, NVIDIA Quadro P4000 CPU, 32 GB RAM) for Geant4-10.3 and
3Ds Max were used.
Table 1 Shapes and range of dimensions characterizing the CSG-shaped cell
*Each geometrical parameter definition is reported in the corresponding image and data is expressed in μm, ‡ VCy =
cytoplasm volume, § VN = nuclear volume, ǁ VG = Golgi volume. † d(G-N) indicates the minimum distance Golgi-nucleus
Fig. 2 Polygonal Mesh (PM) models in 3Ds Max. Cytoplasm, Golgi and nucleus are shown in red, yellow
and blue, respectively. The scale bar is 30 μm
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Parameter analysis of S values
The truncated cone geometry was generated in MCNP6.1 to assess the influence of sev-
eral cell dimensions (1900–5500 um3, as observed from the cell sample), nucleus pos-
ition within the cell (on 2 coordinates), cell-to-cell proximity (from 0 to 5 cell
diameters), and radiation source location (cytoplasm, cell membrane, Golgi) on the cal-
culated S values considering the nucleus as target volume (Fig. 3). Cells were placed ad-
herent to the bottom of one of the wells in a 12-well culture dish plate and adjacent to
each other (excluding cell proximity analysis where they are equally spaced). In all sim-
ulations, the total number of cells was fixed on the basis of the average range of beta
particles emitted by lutetium-177 (280 μm). The total cross-dose was scored on the
nucleus of the central cell, placing the activity in the selected compartment of all the
surrounding ones.
Absorbed dose calculations
The absorbed dose to the nucleus (D(N)) for all the cellular geometries was calculated
applying the MIRD formalism:
D Nð Þ ¼ ~AM  SN←M þ ~ACS  SN←CS þ ~AC  SN←C ð1Þ
where SN M, SN CS and SN C are the absorbed doses to the nucleus per decay from
medium, cell membrane, and inside the cell (cytoplasm or Golgi). The cumulated activ-
ities inside the cell ð~ACÞ, membrane bound ð~ACSÞ and in medium ð~AMÞ were evaluated
in the first 4 h integrating the time-activity curves; in the next 6 days, they were evalu-
ated as follows:
Fig. 3 Schematic summary of the simulations performed for the parameter analysis with the truncated
cone geometry (green area) and the in vitro experiment (red area). The position shifts of the nucleus are
referred to the z- and y-axis. The relative distance between cells is indicated as multiples of the cell radius
(“r”). Regarding the simulation of the in vitro experiment, during the 4-h uptake, the distance between cells
was assumed constant and evaluated on average (1 cell diameter); in the next 6 days, cells were able to
form colonies made of neighboring cells
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~AM;C or CS ¼ f M;C or CS 
Z T2
T 1
A0  e−λptdt ð2Þ
where A0 is the initial added activity, T1 and T2 correspond to time intervals of 24 h,
except for the first day lasting 20 h, and λp is the physical decay constant of the radio-
pharmaceutical; fM, fC, fCS are the fractions of activity localized in medium, cell, or
membrane, respectively, and corrected for decay and cell growth ( fC and fCS divide the
cumulated activity per number of cells measured in each day). The absorbed dose to
the radioactive cell (self-dose) and to each one of the neighboring cells (cross-dose) was
determined; the total cross-dose was reported.
Simulation set-up of the clonogenic survival assay
During the 4 h uptake the distance between cells was assumed constant and evaluated on
average (1 cell diameter) (Fig. 4). Both self- and cross-dose from equally spaced cells was
evaluated, assuming an infinite medium. In the next 6 days, the distance between cells was
changed according to the proliferation rate going from isolated cells to clusters of cells of
increasing sizes, depending on the day. Only the progeny was considered to contribute to
the cross-dose. All cells were assumed to be clonogenic with a doubling time of 27–44 h
calculated using the growth rate obtained by SRB assay [17]. The activity was assumed to
be homogenously distributed among the cell population and equally split to the offspring.
The fraction of activity localized inside the cell ð f C ; ~ACÞ was assumed to be distributed
either in the cytoplasm ð f CY ; ~ACY Þ or in the Golgi ð f G; ~AGÞ.
Statistical methods
The absolute error on the absorbed dose was evaluated by propagating the error
obtained as one standard deviation (SD) of the following components:
– Fractions of activities (5–33%)
– Cell counts (11–18%)
– Added activities (1–3%)
– Variance in S value due to 9 different cell shapes (18–27%)
Fig. 4 Representation of the simulation environment. a Rendering of a 12 well plate with the simulated
cylindrical geometry superimposed on the side view. b Section of the bottom of the cylindrical well with
the reference cell sample (4 h set-up) lying on top
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Selection of the most likely curve fitting result was performed using the Akaike Infor-
mation Criterion (AIC) that takes the goodness of fit and degrees of freedom into
account; fitting was performed according to the least square method, with Pearson’s R2
as parameter for its goodness (R2 > 0.7).
The paired t test was used to assess the significant difference (p < 0.05) between sets
of data within the shape modeling comparison and parameter analysis.
Results
Parameter analysis
Simplified cellular shapes (MIRDcell) result in higher self S values than PM geometry
In previous studies, simplified geometries reproducing cellular morphologies were
compared to analyze the impact of shape-modeling on the S values; therefore we have
further explored this comparison including, as reference, the reconstruction of 9
confocal microscope images of U2OS+SST2 cells with voxels and polygonal meshes.
The S values comparison between different cellular morphologies (MIRDcell, truncated
cone, voxel structures, and PM models) with comparable volumes is reported in Add-
itional file 1: Table S1. In summary, the truncated cone geometry reduces the S values for
N← Cy and N← CS on average by 39 ± 3% (p < 0.05) and 13 ± 10% (p < 0.05), respect-
ively, compared to spheres. PM geometries decrease these differences further to 60 ± 6%
(p < 0.05) for N ← Cy and 37 ± 5% (p < 0.05) for N ← CS, compared to spheres. As ex-
pected, there is no significant difference in the S value when comparing the most realistic
cell representations: voxelized and PM structures (p > 0.05); specifically, the average
relative percentage difference (RPD) between the two sets of S values is 14.8%. The S
values for the PM models are reported in Table 2.
An example is shown comparing a typical cell morphology (Fig. 5a) with a truncated
cone (Fig. 5b) and sphere (Fig. 5c) of similar volumes (Rc = 9μm; Rn = 6μm). Assuming
the PM geometry as reference, the sphere morphology leads to an overestimation of
the absorbed dose to the nucleus from cytoplasm and cell membrane of 65% and 42%,
respectively; refining the cellular representation with a CSG shape, such as the trun-
cated cone, decrease this discrepancy to 43% and 18%, respectively.
Table 2 Self-dose from cytoplasm, Golgi, and cell membrane to nucleus for each of the 9 PM
geometries
Cell n° a VC
c
[μm3]
VN
d
[μm3]
S(N ← Cy)
½ GyBq s
S(N ← G)
½ GyBq s
S(N ← CS)
½ GyBq s
1 3603 1334 4.64E−05 6.96E−05 5.16E−05
2 3466 1374 6.67E−05 1.05E−04 6.39E−05
3 1877 721 7.05E−05 1.22E−04 7.79E−05
4 1853 722 7.27E−05 5.41E−05 7.66E−05
5 3932 1004 5.10E−05 8.57E−05 4.79E−05
6 4228 1096 5.30E−05 1.32E−04 4.60E−05
7 4149 1155 6.46E−05 1.05E−04 5.63E−05
8 3495 915 5.78E−05 8.12E−05 5.70E−05
9 5309 1231 4.27E−05 8.71E−05 4.20E−05
Average 3546 ± 1104b 1061 ± 241b 5.84E−05 ± 1.08E−05b 9.35E−05 ± 2.48E−05b 5.77E−05 ± 1.28E−05b
aAs reported in Fig. 2, b one standard deviation. c VC = cellular volume,
d VN = nuclear volumes
Tamborino et al. EJNMMI Physics             (2020) 7:8 Page 8 of 19
Cell size and source location affects self S value
In previous studies, cytoplasm and membrane placements were compared for the
spherical model. We have furthered explored this comparison using the more real-
istic truncated cone geometry, including the Golgi and combining the effect of cell
dimension.
Both SN ← Cy and SN ← CS decrease exponentially (R
2 = 0.98 and R2 = 0.97, re-
spectively) with increasing cell volumes. For instance, reducing the average cell vol-
ume (3500 μm3) to the smallest volume observed (1900 μm3), leads to an increase
in the absorbed dose of 56% and 43% for cytoplasm and cell membrane, respect-
ively. Whereas increasing its volume to the largest volume observed (5500 μm3)
leads to a reduction in the self-dose of 30% for Cy and 24% for cell membrane
(Fig. 6a; Additional file 1: Table S2).
Furthermore, the sub-cellular distribution of the radionuclide significantly affects the
self-absorbed dose (p < 0.05 comparing cytoplasm and cell membrane). The nucleus
Fig. 5 Effect of accurate shape modeling on the self-dose to the nucleus. a Example of a typical cell
morphology with the corresponding S values from cell surface and cytoplasm. The same S values
corresponding to the sphere b and truncated cone c when selecting similar volumes are reported for
comparison. VC and VN indicate the cellular and nuclear volume, respectively
Fig. 6 Effect of cellular volume and source location on the self-dose a and cross-dose b dose to nucleus.
Square, triangle and circle correspond to the radioactive source distributed in cytoplasm, membrane and
Golgi, respectively
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receives a higher dose from the cytoplasm rather than from the cell membrane; specif-
ically, the smaller the cell the larger the dose contribution given by the cytoplasm com-
pared to the cell membrane, assuming the same activity in both compartments.
Only cell size affects the cross S value
The same analysis reported above has been performed on the total cross-dose imparted
by touching cells, as described in the “Parameter analysis of S values” section. As the
volume increases the total cross-dose decreases exponentially. For instance, it increases
on average with 63% when reducing the average cell volume to 1900 μm3 and reduces
its value of 28% when increasing the average cell volume to 5500 μm3, showing no de-
pendency on the source location (Fig. 6b; Additional file 1: Table S3).
The ratio of total cross- to self-dose is on average 23% ± 1% from cytoplasm to nu-
cleus and 28% ± 2% from cell membrane to nucleus, depending on the cell dimension.
Therefore, in a realistic flattened cell representation, such as the truncated cone, the
self-dose outweighs the cross-dose.
Golgi is modeled with polygonal mesh structures
After analyzing the impact of source location in the truncated cone geometry, we have
compared these findings against the PM data reported above in order to assess when
the implementation of voxelized/polygonal mesh structures is deemed necessary.
In the truncated cone representation, simplifying the Golgi as half-circular torus signifi-
cantly underestimates the radiation potentially imparted by this organelle (Table 3). Indeed,
the complex structure of the Golgi, made of several vesicles distributed at variable distances
from the nucleus, makes an accurate CSG representation challenging. Therefore, only the
PMs allowed to take into account the alleged translocation of lutetium-177 to the Golgi
(S(N ← G)) accurately, resulting in an increased absorbed dose to the nucleus of + 64% (aver-
aged over 9 PM models) with a maximum + 149% (corresponding to cell 6) when compared
to a homogeneous distribution of the activity in the cytoplasm (S(N ← CY)) (Table 2).
Table 3 Comparison between the doses delivered by Golgi to nucleus for 2 geometrical
assumptions: PM models and simplified CSG. The data are listed in increasing order of Golgi
volume (Vg)
PM
Vg (μm3)
S(N ← G)
½ GyBq s
CSG
Vg (μm3)
S(N ← G)
½ GyBq s
123 1.05E−04 110 3.67E−05
80 8.71E−05 94 3.70E−05
68 1.05E−04 86 3.75E−05
63 1.32E−04 78 3.60E−05
60 8.57E−05 70 4.40E−05
54 8.12E−05 62 4.78E−05
31 6.96E−05 54 6.32E−05
25 5.41E−05 46 6.71E−05
24 1.22E−04 38 8.87E−05
Average (9.4±2.5) E−05 Average (5.1±1.8) E−05
Cell volumes: 1900 ÷ 5500 μm3 and nucleus volumes: 570 ÷ 1652 μm3, corresponding to reference MIRD cell with Rc = 8 ÷
11 μm and Rn = 6 ÷ 7 μm
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Cross-dose is negligible above 5 cells distance for equally spaced cells
In order to analyze the cross-dose imparted by non-neighboring cells and to model the
multicellular monolayer geometry during the first 4 h exposure, we have investigated
the effect of cell proximity. For this purpose, we compared the total cross-dose, when
average-sized cells are plated at a given distance between each other with respect to the
reference case of touching cells, using the truncated cone geometry. The total
cross-dose, which is already a minor contribution of the total dose compared to
the self-dose, is reduced with 82% at 1 cell diameter (average cell distance during
the uptake experiments). At 5 cell diameters it becomes negligible (− 99% of refer-
ence value), leading to the assumption that the absorbed dose imparted from cells
located further away from each other can be disregarded. Coherent with the previ-
ous findings, there is no significant difference in the total cross-dose between
source locations (Additional file 1: Table S4).
Nucleus placement does not affect S value for cytoplasm and cell membrane
In previous studies, the effect of non-concentric cell and nucleus morphology for the
spherical cell model was reported. Therefore, we have explored the effect of nucleus
placement in our truncated cone geometry.
Shifting the nucleus position has little influence (up to 4%) on the self- and cross-
dose imparted by the cytoplasm or cell membrane to the nucleus. Instead, a dose
reduction of 15–36% is observed when placing the source in the Golgi and shifting the
nucleus away of 1–3 μm from it longitudinally (on y-axis), implying that modeling the
Golgi few μm away from the nucleus could significantly affects the final absorbed dose
calculation (Additional file 1: Table S5-S6).
Dosimetry of clonogenic survival assay
High-resolution time-activity cellular uptake curves
The membrane-bound activity per cell saturates within the first 15 min thus show-
ing a linear function with incubation time, whilst the internalized fraction reaches
a plateau after 2 h (exponential association function; R2 > 0.95) (Fig. 7a, b). In
addition, the decay-corrected membrane-bound and internalized activities per cell
quantified each subsequent day show an exponentially decreasing trend (R2 > 0.94)
(Fig. 7c, d; Additional file 1: Table S7).
After the first 4 h of incubation, lutetium-177 is released into the medium because of
active or passive excretion and cell death (Additional file 1: Figure S1). The effective
decay rate is 0.024 ± 0.002 h−1.
MIRDcell predicts higher absorbed doses than PM models
Following, the absorbed dose delivered by medium, cytoplasm/Golgi and cell membrane
is calculated each day (Fig. 8) using the S values reported in Table 4 (see Additional file 1:
Table S8 for the other geometrical assumptions). The medium fraction only contributes
significantly (10–17%) to the dose imparted to the nucleus during the first 4 h (during in-
cubation of the cells with 177Lu-DOTATATE). Furthermore, the higher the activity the
more the influence of the unbound fraction on the absorbed dose during the first 4 h.
Throughout the 6 days, the internalized fraction forms the main contribution to the
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absorbed dose to the nucleus because of the greater radionuclide uptake; its contribution
corresponds to 82% and 73% of the total absorbed dose to the nucleus for the low-
est and highest added activity, respectively. Eventually, the absorbed dose imparted
by each cell compartment decreases, because of excretion, cell death, and physical
decay of lutetium-177. The cumulative absorbed dose to the nucleus is reported
for four scenarios: spheres, truncated cones and the PM geometry considering the
internalized fraction either in the cytoplasm or Golgi (Table 5). Calculating the
absorbed dose using each of the 9 PM models separately, we estimated that the
final absorbed dose to the nucleus might differ up to ± 21% and ± 31% when the
source is localized in cytoplasm or Golgi, respectively.
177Lu-DOTATATE and x-ray exposure cause different dose-responses
After calculating the absorbed dose to the nucleus, we sought correlations with the experi-
mental survival fractions (SF). The SF versus the absorbed dose to the nucleus after 86-keV
x-ray irradiation and 177Lu-DOTATATE exposure (MIRDcell and PM models) is plotted in
Fig. 9. The survival data of the x-ray irradiation could be fitted by the LQ-model (R2 = 0.99)
with the following parameters α = 0.27 ± 0.08/Gy and β = 0.23 ± 0.06 /Gy2, α/β = 1.19 ±
0.67Gy. Instead, for the 177Lu-DOTATATE survival data, the Akaike test showed as pre-
ferred fitting model the linear dose-response (α/β > 100Gy); the corresponding α value for
all the modeling assumptions are reported in Table 6. The absorbed doses calculated by
implementing MIRDcell S values exceeded the dose-range of the x-ray irradiation.
Fig. 7 Activity quantification. Internalized a and b membrane bound activity curves per cell during the 4 h
uptake. Internalized c and d membrane bound activity per cell at the end of the 4 h uptake and in each
following day. The curves corresponding to 0.1 MBq/ml and 0.25 MBq/ml are extrapolated. The error bars
indicate the SD of uptake data
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Fig. 8 Absorbed dose contribution to the nucleus from unbound, membrane bound and internalized
fraction of activity (in cytoplasm) through the experiment. a corresponds to 0.1 MBq/ml and b to 2.5 MBq/ml.
Calculations were performed using the avarage S values of the 9 PM geometries, including the varying cross
dose. The error bars indicate the SD of the absorbed dose
Table 4 S values calculated for the 4-h uptake (cellular distance of 1 diameter) and the 6-day
colony forming (from single cells to clusters of increasing size) for polygonal mesh models and
localization of the internalized source in cytoplasm or Golgi
Polygonal mesh Medium
Source S(N ← CS)
a b S(N ← Cy)
a b S(N ← G)
a b
4-h uptake 6.17E−05 6.23E−05 9.75E−05 9.43E−12
Colony day-1 5.77E−05 5.84E−05 9.35E−05 9.43E−12
Colony day-2 6.07E−05 6.13E−05 9.65E−05
Colony day-3 6.66E−05 6.70E−05 1.02E−04
Colony day-4 7.30E−05 7.33E−05 1.08E−04
Colony day-5 7.73E−05 7.76E−05 1.13E−04
Colony day-6 8.01E−05 8.03E−05 1.15E−04
aMean monolayer S values (N← CS, N← Cy, N← G), which is the sum of self and cross-dose to the nucleus in [Gy/(Bq s)].
bS(N ← CS)±1.28E-05, S(N ← Cy)±1.08E-05 and S(N ← G)±2.48E−05. The SD is given only by the variation in the self-S
value contribution
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Discussion
For the evaluation of novel radiopharmaceuticals, an accurate assessment of the cell-
absorbed dose is crucial to get more insight into the aspects enabling a clinically effect-
ive treatment. Therefore, we first systematically analyzed the impact of several cellular
parameters on the self- and cross-dose contributions from intracellular radiation expo-
sures. Next we developed a dosimetric model for the calculation of the average
absorbed dose during 2D in vitro experiments including morphological (cell size,
shape) and cell culture characteristics (proliferation, proximity variation, cell death)
combined with detailed activity uptake kinetics.
For this purpose, we compared S values obtained for the same cellular shape in
MCNP6.1 and Geant4-10.03 for concentric spheres (including MIRDcell) and truncated
cones. The relative deviation between the codes was small (< 5%) and could be attrib-
uted to several factors: (1) the inclusion of δ-rays and energy-loss straggling in Monte
Carlo calculations ignored by MIRDcell [10], (2) the use of a different cellular compos-
ition rather than water [28], (3) the use of different cross-sections and (4) β-spectra.
Receptor-mediated endocytosis of the radiolabeled peptides plays a crucial role in
causing cytotoxic effects for β-emitters, because of the large number of β traversals
(10000–20000) required for cell killing [29]. Therefore, the quantification of cellular
Table 5 Absorbed dose to the nucleus corresponding to each added activity for the 4 geometrical
modeling assumptions
Activity
[MBq/ml]
Sphere
[Gy]
TCa (Cy)b
[Gy]
PM (Cy)b
[Gy]
PM (G)b
[Gy]
0.1 0.42 ± 0.05 0.20 ± 0.02 0.14 ± 0.04 0.20 ± 0.07
0.25 1.08 ± 0.13 0.52 ± 0.06 0.35 ± 0.09 0.51 ± 0.18
0.5 2.77 ± 0.30 1.39 ± 0.15 0.92 ± 0.25 1.36 ± 0.47
1 2.63 ± 0.36 1.36 ± 0.18 0.92 ± 0.25 1.33 ± 0.47
2.5 5.64 ± 0.96 2.95 ± 0.47 2.04 ± 0.60 2.86 ± 1.08
a TC=Truncated cone. b The localization of the internalized source is indicated in parenthesis
Fig. 9 Dose-response curves corresponding to x-ray irradiation (top left) and 177Lu-DOTATATE (top right:
MIRDcell, bottom left: PM with internalized source in cytoplasm, bottom right: PM with internalized source
in Golgi). Each data point is plotted as the mean survival±SEM
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uptake is a critical step to accurately estimate the effect of PRRT. However, the com-
mon protocol found in literature for determining the cellular uptake of radioactivity
foresees one time point after saturation of the receptors [30], while our cellular uptake
dataset allows for a more accurate quantification of the time integrated activity.
Many research groups have investigated the cellular uptake of radioactivity in cell
populations and found lognormal distributions of activity, including a fraction of
non-radiolabeled cells, which could lead to an increase in survival fractions. How-
ever, due to the lack of evidence on uptake heterogeneity in our cells, we assumed
a uniform activity distribution among cells. Marcatili et al. investigated the impact
of heterogeneity of uptake between cells and change in geometrical configurations
for lutetium-177-labeled antibodies finding a variation of 24% on the cross-dose
when randomizing both these parameters. When applying such an uncertainty on
our data this would not significantly affect (< 5%) the absorbed dose, since in our
study the cross-dose was found to be a minor contributor to the total absorbed
dose. Instead, the heterogeneity of cells morphology and sub-cellular uptake re-
sulted to be the major factors affecting the absorbed dose. Noticeably, if the frac-
tion of labeled cells decreases, it becomes even more crucial to improve the
cellular modeling to reproduce the subcellular distribution of the radionuclide and
accurately estimate the self-dose [31].
Cellular modeling can significantly influence the proximity of the cell membrane and
cytoplasm to the nucleus and thus the self S value [13]. Differences in S values between
spherical and truncated cone geometry were found to reach 40%. However, accurately
modeling cellular shapes by constructive solid geometries can represent a challenge for
peculiar shapes. Hence, simplified representations, such as the truncated cone, should
be used with caution in these cases. Using polygonal mesh structures we could model
the cell membrane closer to the nucleus than in any other simplified constructive solid
geometry representation, revealing that the absorbed dose delivered by the cell mem-
brane is comparable to the cytoplasm for the same cumulated activity, conversely to
spheres or truncated cone geometry results.
Furthermore, geometrical approximations of organelles such as the Golgi, where the
SST2 receptor and hence possible the lutetium-177, is located upon internalization
within 15 min, largely affect the absorbed dose to the nucleus as well. Modeling the
Golgi with half circular torus close to the nucleus leads to a significant underestimation
(up to 73%) of the absorbed dose compared to polygonal meshes. Remarkably, its struc-
tural arrangement and proximity to the nucleus increases the absorbed dose to the
nuclear target compared to uniform radionuclide distribution in the cytoplasm. Notice-
ably, the characterization of the internalized source distribution and the geometry of
the targeted cells would become even more critical when using alpha- or Auger-
radiations [14], due to their short range.
Table 6 The LQ-model parameter α calculated for the x-ray irradiation and the 4 modeling
assumptions adopted for the 177Lu-DOTATATE exposure (with α/β > 100 Gy): MIRDcell, truncated
cone, and PM assuming the internalized source either in cytoplasm (PM-Cy) or Golgi (PM-G)
x-ray MIRDcell Truncated cone PM-Cy PM-G
α ½ 1Gy 0.27 ± 0.08 0.19 ± 0.20 0.32 ± 0.38 0.47 ± 0.19 0.33 ± 0.13
R2 0.99 0.67 0.66 0.65 0.66
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The outcome of our parameter analysis confirmed that both cell size and source loca-
tion affect the self S value, whilst the cross S value is affected only by the cell size in all
the tested geometries [7, 31].
Besides a better characterization of the cellular morphology, Marcatili et al. [30]
proved the necessity of modeling the whole cell culture geometry, such as cell proxim-
ity and colony formation when involving β-emitters, since changes in these parameters
can significantly modify survival curves. We found that the cross-dose contribution to
the total absorbed dose would be overestimated (+ 15%) if neighboring cells are mod-
eled as is generally considered in past studies [8], rather than cells placed at 1 diameter
as was done in our study. Moreover, during the follow-up days, we included the cross-
dose contribution by the cellular clusters newly formed due to proliferation, which was
not taken into consideration in past studies as well [29, 30]. We found out that the
cross-dose contribution, within a cluster, increased linearly with the number of days,
reaching 16% of the total absorbed dose. On the other hand, the neighboring clusters
were located further away than the average range of lutetium-177 electrons from the
cluster to which the target cell belongs, thus their cross-dose contribution could be
neglected.
As expected, the absorbed dose to the nucleus seemed to better match the survival
trend rather than the added activity; increasing the added activity from 0.5MBq/ml to
1MBq/ml did not alter the survival (~ 50%), because of the equivalent cumulated activ-
ities in the different cell compartments, which lead to similar absorbed doses to the nu-
cleus. The absorbed dose to the nucleus was found to be 3-fold higher for spheres
(MIRDcell) compared to the polygonal mesh structures.
Establishing the correlation between absorbed dose to the nucleus and clonogenic sur-
vival, we found out that the linear quadratic-model fits both 177Lu-DOTATATE (with β =
0) and x-ray irradiation survival data (with β ≠ 0). The linear-model relies on the assump-
tion of a high α/β or a short sub-lethal damage repair half-life, thus ignoring the quadratic
term of the linear quadratic-model. The heterogeneous dose delivery, the very low dose-rate
(< 0.1 Gy/h) and the protracted exposure might account for the differences in the survival
curves. Indeed, the low dose-rate could cause defects in the detection of low levels of DNA
damage and the synchronization of cells in a radiosensitive cell cycle phase [1]. This could
explain the significant drop of the survival in the low dose-range and thus, the alpha value
discrepancy between x-ray and 177Lu-DOTATATE exposures. We neglected morphological
or radiation sensitivity changes during proliferation (S-phase) as well as the effect of dose-
rate variation between 6 days (150 to 7mGy/h for 2.5MBq/ml), which can play a significant
role in PRRT [1]. In addition, further modeling refinement can be achieved by implement-
ing more realistic biochemical mechanisms (advanced knowledge on source distribution
within the cell compartments, pinocytosis, etc.) and studying absorbed doses on different
cellular targets (e.g., cytoplasm [32], mitochondria [33], cell membrane [34], entire cell [35],
and the Golgi apparatus [36]). Besides, we did not include repopulation, bystander effects,
and changes in radio-sensitivity as well as in geometry and Golgi-placement [37] throughout
the cell cycle. Although this was beyond the scope of the current study, the development of
our cellular dosimetry model will enable to investigate these aspects.
At present, clinical dosimetry does not take the typical complexity and heterogeneity
at the cellular or multi-cellular level into account. Instead, characterizing the absorbed
dose on micro-scale, not only relying on averaged large-scale dosimetry, is necessary to
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assess the biological response and be able to implement this information on a clinical
scale. The natural extension of these in vitro experiments could be the investigation of
the ability of the linear dose-response model to predict tumor control probability in
pre-clinical animal models of this particular cancer type.
Conclusion
Altogether these results indicate that accurate modeling of cellular shapes and organ-
elles in order to sample the radionuclide distribution is crucial to better estimate the
absorbed dose to nucleus. Our dosimetry model mimics the experimental design of
in vitro treatments, comprehending realistic cellular features, dynamic changes in pro-
liferation, proximity variations, and cell death. Moreover, it suggests that 177Lu-DOTA-
TATE treatment might be more effective than indicated by average spherical cell
dosimetry.
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